sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Eradicating Misconceptions about Viruses using Multimodal Trace Data in an Intelligent Game-based Environment across Educational Contexts

$261,005

Barrie D Robison · University Of Idaho · R25 · FY2024 · GM

Dysregulated Co-inhibitory Pathways Associated with Severe COVID-19 Immunopathology

$260,931

David A. Hafler · Yale University · P01 · FY2020 · AI

CoVPN 3003 - A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older SDMC

$260,795

Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI

Home vs. Clinic Collection of Human Milk in Evaluating the Pharmacokinetics of Four Medications

$260,215

Christina Chambers · University Of California, San Diego · R21 · FY2021 · HD

Mechanistic & Crystallographic Studies of SARS Proteases

$260,103

Andrew D Mesecar · University Of Illinois At Chicago · P01 · FY2008 · AI

Rewiring SARS-CoV Genome Organization and Pathogenesis

$259,764

Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2007 · AI

Wastewater data integration and modelling to accurately predict community and organizational outbreaks due to viral pathogens

$259,613

Nathan L Tintle · Superior Statistical Research, Llc · R43 · FY2022 · AI

Highly-sensitive, rapid and low cost plasmonic assay platform for Lyme disease diagnosis

$259,613

Ernest Fitch Guignon · Ciencia, Inc. · R41 · FY2022 · AI

Reusable, transparent, and reconfigurable N95-equivalent Respirator Masks: design, fabrication, and trials for enhanced adoption

$259,505

Alice Chun · Seeus95 Inc · R41 · FY2022 · DC

Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses

$259,500

Thomas M. Aune · Vanderbilt University Medical Center · R21 · FY2022 · AI

Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes

$259,500

Leigh Meredith Howard · Vanderbilt University Medical Center · R21 · FY2022 · AI

Rapid Production of Metal Organic Framework - Fabrics for Air Filtration

$259,484

Nick Cienski · Hava, Inc. · R43 · FY2022 · OH

Serological and cellular immune response to SARS-CoV-2 vaccination in pediatric multiple sclerosis on immunotherapy

$259,468

Grace Yoonheekim Gombolay · Emory University · R21 · FY2025 · AI

Development of therapeutics for SARS-CoV-2 infection

$259,439

Hiroaki Mitsuya · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Defining the optimal type and timing of COVID-19 vaccine in pregnancy

$259,350

Ai-Ris Yonekura Collier · Beth Israel Deaconess Medical Center · R21 · FY2023 · AI

The Development of CSD peptides for the therapeutic treatment of post-acute sequelae of COVID-19 (PACS)

$259,332

Breanne Mackenzie · Lung Therapeutics, Inc. · R43 · FY2023 · HL

Antibody display libraries for precision screening of antibody immune responses to SARS-CoV-2

$259,300

Brandon James Dekosky · University Of Kansas Lawrence · DP5 · FY2020 · OD

Persistence and Evolution of SARS-CoV-2

$259,259

Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Developing a resiliency intervention to support healthcare workers engaged in the provision of HIV care

$259,244

Christina Psaros · Massachusetts General Hospital · R34 · FY2023 · MH

Prenatal endocrine-disrupting chemicals, pandemic-related stress and social risk in mothers and infants

$259,200

Julie Beth Herbstman · Columbia University Health Sciences · R21 · FY2023 · ES

Interrogating inflammatory responses to SARS-CoV-2 infection in vivo

$259,076

Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Eradicating Misconceptions about Viruses using Multimodal Trace Data in an Intelligent Game-based Environment across Educational Contexts

Dysregulated Co-inhibitory Pathways Associated with Severe COVID-19 Immunopathology

CoVPN 3003 - A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older SDMC

Developing RNA Vaccines to Treat Peanut Hypersensitivity

Immunity to SARS-CoV-2 After Natural Infection or Vaccination

Point-of-care diagnostic for amplification and detection of SARS-CoV-2 RNA

Antiviral T cell Responses During SARS-CoV-2 Infection

Home vs. Clinic Collection of Human Milk in Evaluating the Pharmacokinetics of Four Medications

Mechanistic & Crystallographic Studies of SARS Proteases

Rewiring SARS-CoV Genome Organization and Pathogenesis

Wastewater data integration and modelling to accurately predict community and organizational outbreaks due to viral pathogens

Highly-sensitive, rapid and low cost plasmonic assay platform for Lyme disease diagnosis

Reusable, transparent, and reconfigurable N95-equivalent Respirator Masks: design, fabrication, and trials for enhanced adoption

Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses

Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes

Rapid Production of Metal Organic Framework - Fabrics for Air Filtration

Serological and cellular immune response to SARS-CoV-2 vaccination in pediatric multiple sclerosis on immunotherapy

Development of therapeutics for SARS-CoV-2 infection

Defining the optimal type and timing of COVID-19 vaccine in pregnancy

The Development of CSD peptides for the therapeutic treatment of post-acute sequelae of COVID-19 (PACS)

Antibody display libraries for precision screening of antibody immune responses to SARS-CoV-2

Persistence and Evolution of SARS-CoV-2

Developing a resiliency intervention to support healthcare workers engaged in the provision of HIV care

Prenatal endocrine-disrupting chemicals, pandemic-related stress and social risk in mothers and infants

Interrogating inflammatory responses to SARS-CoV-2 infection in vivo